Document Detail


Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers.
MedLine Citation:
PMID:  15819388     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of this study was to compare the influences of antianginal drugs such as mononitrate, beta-blocker and calcium channel blocker on cardiovascular responsiveness to orthostasis. METHODS: The responses to passive orthostasis (tilt provocation at 60 degrees for 3 min) were measured in normotensive healthy volunteers with whole-body impedance cardiography and finger blood-pressure monitoring after a single moderate oral dose of isosorbide-5-mononitrate (CAS 16051-77-7, 10 mg), the beta1-blocker bisoprolol fumarate (CAS 104344-23-2, 5 mg), the dihydropyridine calcium channel blocker nisoldipine (CAS 63675-72-9, 5 mg), and placebo in a randomised, double-blind fashion. RESULTS: In supine position, none of the drugs altered pre-tilt arterial pressure or heart rate (HR) when compared to placebo. Nisoldipine decreased systemic vascular resistance index (SVRI) when compared to either placebo or bisoprolol, and increased the cardiac index (CI) when compared to placebo. During the passive orthostasis, the mononitrate decreased SVRI when compared to placebo or bisoprolol. The mononitrate increased HR and pulse wave velocity (PWV) when compared to the other study groups, and decreased the stroke index when compared to placebo. In the bisoprolol group, the tilt responses of diastolic arterial pressure, HR, CI, left cardiac work index, and PWV decreased significantly compared to those in the placebo group. Nisoldipine did not alter the responses to orthostasis when compared to placebo. When compared to the mononitrate, both nisoldipine and bisoprolol decreased CI response to orthostasis. CONCLUSIONS: The mononitrate adversely affects the cardiovascular responsiveness to orthostasis. The beta-blocker reduces the responses and thus probably oxygen demand during orthostasis. The dihydropyridine calcium blocker seems to influence the responsiveness less than the mononitrate or beta-blocker.
Authors:
Ritva Ylitalo; Mika Kähönen; Tuomo Nieminen; Tiit Kööbi; Pauli Ylitalo; Väinö Turjanmaa
Related Documents :
7037098 - Propranolol in experimentally induced stress.
22550828 - Correlation between inferior vena cava diameter and central venous pressure in critical...
23740668 - The angiogenic peptide vascular endothelial growth factor-basic fibroblast growth facto...
22649498 - Back to basics: pitting edema and the optimization of hypertension treatment in inciden...
19219508 - Stroke volume variation as a predictor of intravascular volume depression and possible ...
18764158 - Onset of mechanical stability in random packings of frictional spheres.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Arzneimittel-Forschung     Volume:  55     ISSN:  0004-4172     ISO Abbreviation:  Arzneimittelforschung     Publication Date:  2005  
Date Detail:
Created Date:  2005-04-11     Completed Date:  2005-05-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372660     Medline TA:  Arzneimittelforschung     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  160-6     Citation Subset:  IM    
Affiliation:
Department of Pharmacological Sciences, University of Tampere Medical School, Tampere, Finland. ritva.ylitalo-heikkala@medfiles.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology*
Adult
Calcium Channel Blockers / pharmacology*
Dihydropyridines / pharmacology*
Double-Blind Method
Female
Hemodynamics / drug effects*,  physiology*
Humans
Hypotension, Orthostatic / drug therapy*,  physiopathology
Isosorbide Dinitrate / analogs & derivatives*,  pharmacology*
Male
Nisoldipine / pharmacology
Nitric Oxide Donors / pharmacology*
Receptors, Adrenergic, beta-1 / antagonists & inhibitors*
Supine Position / physiology
Tilt-Table Test
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 0/Dihydropyridines; 0/Nitric Oxide Donors; 0/Receptors, Adrenergic, beta-1; 16051-77-7/isosorbide-5-mononitrate; 63675-72-9/Nisoldipine; 87-33-2/Isosorbide Dinitrate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.
Next Document:  Effects of 15-deoxy-delta(12,14)-prostaglandin J2 on nuclear localization of GATA-3 in the murine lu...